Anatomic & Clinical Pathology in Newport Beach, CA
15 verified anatomic & clinical pathology doctors in Newport Beach.
Pathologists diagnose disease by examining tissue, blood, and other lab specimens.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Howard Epstein, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Janet Stallman, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. William Wolfson, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Arell Shapiro, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Denise Van Horn, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Francis Heinemann, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Thomas Lee, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Nazila Zekry, MD
Anatomic & Clinical Pathology
CMS Open Payments· $16.16 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$16.16
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Nazila Zekry do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Veronica Rausei-Mills, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Katie Wilkinson, MD
Anatomic & Clinical Pathology
CMS Open Payments· $720.10 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$720.10
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to Katie Wilkinson do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Thomas Heinz, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. John Cupp, MD
Anatomic & Clinical Pathology
CMS Open Payments· $16.54 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$16.54
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to John Cupp do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Monica Mosquera Caro, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. David Braxton, MD
Anatomic & Clinical Pathology
CMS Open Payments· $8,012 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$8,012
Total received
4
Transactions
3
Paying companies
Top paying companies
Among the 16,988 anatomic & clinical pathology doctors we've analyzed, about 17% received any industry payment (median $71 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US anatomic & clinical pathology doctors.
Payments to David Braxton do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ali Nael Amzajerdi, MD
Anatomic & Clinical Pathology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.